Corvus Pharmaceuticals In... (CRVS)
5.00
0.27 (5.71%)
At close: Jan 17, 2025, 3:59 PM
5.01
0.10%
After-hours Jan 17, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Net Income | -27.03M | -41.31M | -43.24M | -6.00M | -46.67M | -46.94M | -55.66M | -36.38M | -31.34M | -175.64K |
| Depreciation & Amortization | 151.00K | 367.00K | 460.00K | 632.00K | 743.00K | 847.00K | 842.00K | 594.00K | 148.00K | n/a |
| Stock-Based Compensation | 2.15M | 2.69M | 4.23M | 5.75M | 7.35M | 7.13M | 6.23M | 3.83M | 428.00K | n/a |
| Other Working Capital | -3.71M | 1.08M | -827.00K | 890.00K | 1.45M | 33.00K | 1.02M | 2.93M | 592.00K | 8.73K |
| Other Non-Cash Items | 4.39M | 9.81M | 5.07M | -37.07M | -644.00K | -608.00K | -195.00K | 4.48M | 17.64M | 62.18K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.83M | -41.00K | n/a |
| Change in Working Capital | -3.59M | 1.41M | -3.24M | 1.91M | 1.90M | -1.42M | 2.58M | 3.45M | 1.83M | 8.73K |
| Operating Cash Flow | -23.93M | -27.02M | -36.72M | -34.78M | -37.32M | -40.99M | -46.21M | -27.86M | -11.33M | -104.73K |
| Capital Expenditures | -34.00K | -269.00K | -5.00K | -76.00K | -25.00K | -355.00K | -266.00K | -2.20M | -1.75M | n/a |
| Acquisitions | n/a | 22.00K | -21.57K | -44.84K | -3.28K | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -47.05M | -66.19M | -9.36M | -42.54M | -138.59M | -161.86M | -88.31M | -258.28M | -104.39M | n/a |
| Sales Maturities Of Investments | 62.62M | 43.16M | 30.92M | 87.39M | 141.87M | 132.02M | 173.40M | 217.92M | 14.10M | n/a |
| Other Investing Acitivies | n/a | -23.01K | 21.57K | 44.84K | 3.28K | -29.84M | 85.09M | -40.36M | -90.28M | n/a |
| Investing Cash Flow | 15.54M | -23.28M | 21.56M | 44.77M | 3.25M | -30.19M | 84.83M | -42.56M | -92.03M | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 24.00K | n/a | 1.22M | 88.00K | 24.00K | 393.00K | 731.00K | 4.00K | 94.95M | 13.76M |
| Financial Cash Flow | 7.86M | n/a | 62.16M | 1.31M | 24.00K | 65.27M | 1.44M | 71.36M | 94.95M | 13.76M |
| Net Cash Flow | -539.00K | -50.30M | 47.00M | 11.30M | -34.04M | -5.91M | 40.06M | 945.00K | -8.41M | 13.65M |
| Free Cash Flow | -23.97M | -27.29M | -36.72M | -34.85M | -37.35M | -41.34M | -46.48M | -30.06M | -13.07M | -104.73K |